← Back to Search

Contingency Management + Cognitive Behavioural Therapy for Gambling Addiction

N/A
Recruiting
Led By Darren R Christensen, PhD
Research Sponsored by University of Lethbridge
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-weeks
Awards & highlights
No Placebo-Only Group

Summary

This trialwill test if providing rewards to remote gamblers during counselling helps them stay in the program and improve their treatment outcomes.

Who is the study for?
This trial is for English-speaking individuals living in rural or remote areas who have been diagnosed with a gambling disorder and have gambled within the last month. They must be able to give written consent. People with unmanaged psychiatric or neurological conditions, other than gambling disorder, cannot participate.
What is being tested?
The study tests if adding Contingency Management to regular Cognitive Behavioural Therapy (CBT) helps improve attendance and retention in counselling sessions for disordered gamblers using video-conferencing tools designed for those living far from treatment centers.
What are the potential side effects?
Since this trial involves psychological treatments rather than medications, traditional side effects are not expected. However, participants may experience emotional discomfort or stress during therapy sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Gambling Abstinence
Secondary study objectives
Session Attendance
Study Retention

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Contingency ManagementExperimental Treatment1 Intervention
This is a treatment where participants earn points for treatment attendance and for providing evidence of gambling abstinence. These points are added to study accounts that can be redeemed for goods and services available at a variety of on-line businesses (e.g., Amazon, Walmart, etc.). Submission of evidence of gambling behaviour or non-attendance at an on-line counselling session re-sets subsequent points to the starting level. The CM procedure is implemented as part of the CBT counselling session.
Group II: Cognitive Behavioural TherapyActive Control1 Intervention
CBT is currently considered "best practice" for the treatment of problem gambling, as noted in the National Health and Medical Research Council (Australia) endorsed Clinical Guidelines for problem and pathological gambling treatment (Problem Gambling Research and Treatment Centre, 2011). CBT is typically a semi-structured approach for delivering cognitive behavioural therapy addressing the participant's experiences, thoughts, and emotions relating to their gambling and substance use. Techniques include psychoeducation, behavioural interventions, and cognitive strategies. Participants are expected to attend on-line counselling sessions three times a week for approximately 12 weeks. All participants will receive individual counselling from an experienced counsellor/therapist.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contingency Management
2014
Completed Phase 4
~3440

Find a Location

Who is running the clinical trial?

Rural Development NetworkUNKNOWN
University of LethbridgeLead Sponsor
9 Previous Clinical Trials
710 Total Patients Enrolled
Alberta Rural Development NetworkUNKNOWN

Media Library

Cognitive Behavioural Therapy Clinical Trial Eligibility Overview. Trial Name: NCT02953899 — N/A
Compulsive gambling Research Study Groups: Cognitive Behavioural Therapy, Contingency Management
Compulsive gambling Clinical Trial 2023: Cognitive Behavioural Therapy Highlights & Side Effects. Trial Name: NCT02953899 — N/A
Cognitive Behavioural Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT02953899 — N/A
~1 spots leftby Dec 2024